http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03101449-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_875b590d69302482c9b84d73afa08008
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-10
filingDate 2003-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_493757b14602d4e876be19f13507be7c
publicationDate 2004-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03101449-A3
titleOfInvention Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
abstract The present invention relates to a method of making novel dipeptidyl peptidase-IV ('DPP-IV') inhibitor compounds useful for treating, inter alia, diseases that are associated with proteins that are subject to processing by DPP-IV, such as Type 2 diabetes mellitus, metabolic syndrome (Syndrome X or insulin resistance syndrome), hyperglycemia, impaired glucose tolerance, glucosuria, metabolic acidosis, cataracts, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, Type 1 diabetes, obesity, hypertension, hyperlipidemia, atherosclerosis, osteoporosis, osteopenia, frailty, bone loss, bone fracture, acute coronary syndrome, infertility due to polycystic ovary syndrome, short bowel syndrome and to prevent disease progression in Type 2 diabetes. The invention also relates to a method of making 3, 3, 4, 4-tetrafluoropyrrolidine, a starting material utilized in the afore-mentioned method for preparing DPP-IV compounds.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8093236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8324383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102171175-B
priorityDate 2002-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9939135
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25253
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45031
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457328298
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100301982
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397492
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13482

Total number of triples: 27.